Cynata Therapeutics Limited
CYYNF
$0.118
$0.01615.69%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -1.19M | -1.22M | -1.71M | -1.71M | -1.48M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | 44.50K | 45.80K | 46.20K | 46.20K | 45.70K |
| Total Other Non-Cash Items | 191.50K | 196.90K | 224.70K | 224.20K | -147.30K |
| Change in Net Operating Assets | -- | -- | -239.40K | -238.90K | -- |
| Cash from Operations | -953.10K | -980.10K | -1.68M | -1.68M | -1.58M |
| Capital Expenditure | -16.30K | -16.80K | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -16.30K | -16.80K | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 4.00M | 4.00M | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -255.30K | -255.30K | -- | -- | -- |
| Cash from Financing | 2.44M | 2.51M | -- | -- | -- |
| Foreign Exchange rate Adjustments | -69.20K | -71.20K | 48.10K | 48.00K | -48.10K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.40M | 1.44M | -1.63M | -1.63M | -1.63M |